Seamus
Analyst
Guggenheim Securities
Equibles does not estimate personal net worth.
About Seamus
Seamus is recorded as Analyst at Guggenheim Securities. Seamus has spoken on 2 investor events across 2 companies, most recently for Rhythm Pharmaceuticals, Inc. on November 9, 2026. Those appearances were for Rhythm Pharmaceuticals, Inc. (RYTM) and Generate Biomedicines, Inc. (GENB). The companies whose calls Seamus spoke on are classified in the Healthcare sector.
Seamus on recent calls
“Well, good morning, everyone, and thanks for joining us today here for another of Guggenheim's annual conferences, our Healthcare Innovation Conference 2026. To my left is the CEO and President and Chairman of Rhythm Pharmaceuticals, David Meeker.”
“We've made it to the afternoon of day one of the Guggenheim Healthcare Innovations Conference. It's 2026, and, you know, we're all looking forward to more great company data ahead.”
Affiliation history
-
Guggenheim Securities
Analyst
Transcript header (unverified)
Current